Want to join the conversation?
$A's 4Q15 revenue was up 6.2% on a core basis from a year ago. This growth was driven by strength in Pharma, Food, and Diagnostics & Clinical end-markets. Geographically, the company saw core growth across all regions with particular strength in its liquid chromatography offering, CrossLab services & consumables and Diagnostics & Genomics products.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.